9BC8 image
Entry Detail
PDB ID:
9BC8
EMDB ID:
Title:
Cargo-loaded Myxococcus xanthus EncA encapsulin engineered pore mutant with T=4 icosahedral symmetry
Biological Source:
PDB Version:
Deposition Date:
2024-04-08
Release Date:
2024-10-30
Method Details:
Experimental Method:
Resolution:
3.46 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Type 1 encapsulin shell protein EncA
Mutations:I203G, Y204G
Chain IDs:A, B, C, D
Chain Length:281
Number of Molecules:4
Biological Source:Myxococcus xanthus DK 1622
Polymer Type:polypeptide(L)
Description:Encapsulin nanocompartment cargo protein EncC
Chain IDs:E, F, G, H
Chain Length:12
Number of Molecules:4
Biological Source:Myxococcus xanthus DK 1622
Ligand Molecules
Primary Citation
Pore Engineering as a General Strategy to Improve Protein-Based Enzyme Nanoreactor Performance.
Acs Nano 18 25740 25753 (2024)
PMID: 39226211 DOI: 10.1021/acsnano.4c08186

Abstact

Enzyme nanoreactors are nanoscale compartments consisting of encapsulated enzymes and a selectively permeable barrier. Sequestration and colocalization of enzymes can increase catalytic activity, stability, and longevity, highly desirable features for many biotechnological and biomedical applications of enzyme catalysts. One promising strategy to construct enzyme nanoreactors is to repurpose protein nanocages found in nature. However, protein-based enzyme nanoreactors often exhibit decreased catalytic activity, partially caused by a mismatch of protein shell selectivity and the substrate requirements of encapsulated enzymes. No broadly applicable and modular protein-based nanoreactor platform is currently available. Here, we introduce a pore-engineered universal enzyme nanoreactor platform based on encapsulins-microbial self-assembling protein nanocompartments with programmable and selective enzyme packaging capabilities. We structurally characterize our protein shell designs via cryo-electron microscopy and highlight their polymorphic nature. Through fluorescence polarization assays, we show their improved molecular flux behavior and highlight their expanded substrate range via a number of proof-of-concept enzyme nanoreactor designs. This work lays the foundation for utilizing our encapsulin-based nanoreactor platform for diverse future biotechnological and biomedical applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures